国乐

Guole (Shandong) Pharmaceutical Technology is a Chinese pharmaceutical company established in 2021 and headquartered in Heze, Shandong Province. The company is integrated across drug research and development, manufacturing, and commercialization, with a focus on generic pharmaceuticals and clinical development. Its product portfolio and pipeline include treatments for gastrointestinal disorders, respiratory conditions, and oncology. Notably, the company has received approval for Hydrotalcite Chewable Tablets and is actively conducting bioequivalence (BE) trials for generic products such as Vonoprazan Fumarate Tablets and Letrozole Tablets. Guole (Shandong) Pharmaceutical Technology collaborates with clinical institutions and other pharmaceutical companies to advance its pipeline toward commercialization.